Johnell, Kristina

An update on the clinical consequences of polypharmacy in older adults: a narrative review

Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety

Pharmaceutical Practices and Patient OutcomesChronic Disease Management Strategies

Cited by 617

Evidence Supporting the Best Clinical Management of Patients with Multimorbidity and Polypharmacy: A Systematic Guideline Review and Expert Consensus

Muth, C., Blom, J. W., Smith, S. M., Johnell, K., Gonzalez‐Gonzalez, A. I., Nguyen, T. S., Brueckle, M. ‐., Cesari, M., Tinetti, M. E., & Valderas, J. M. (2019) · Journal of Internal Medicine

Pharmaceutical Practices and Patient OutcomesChronic Disease Management Strategies

Cited by 339

Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults

Johnell, K., Jonasdottir Bergman, G., Fastbom, J., Danielsson, B., Borg, N., & Salmi, P. (2017) · International Journal of Geriatric Psychiatry

Pharmaceutical Practices and Patient OutcomesBalance, Gait, and Falls Prevention

Cited by 130

Concurrent Use of Anticholinergic Drugs and Cholinesterase Inhibitors: Register-Based Study of Over 700 000 Elderly Patients

Johnell, K., & Fastbom, J. (2008) · Drugs & Aging

Pharmaceutical Practices and Patient OutcomesCholinesterase and Neurodegenerative Diseases

Cited by 57

Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study

Tang, B., Sjölander, A., Wastesson, J. W., Maura, G., Blotiere, P.-O., Szilcz, M., Mak, J. K. L., Qin, C., Alvarsson, M., Religa, D., et al. (2024) · eClinicalMedicine

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 57

Does Prolonged Education Causally Affect Dementia Risk When Adult Socioeconomic Status Is Not Altered? A Swedish Natural Experiment in 1.3 Million Individuals

Seblova, D., Fischer, M., Fors, S., Johnell, K., Karlsson, M., Nilsson, T., Svensson, A. C., Lövdén, M., & Lager, A. (2021) · American Journal of Epidemiology

Dementia and Cognitive Impairment ResearchHealth disparities and outcomes

Cited by 48

Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry

Enache, D., Fereshtehnejad, S. ‐., Kåreholt, I., Cermakova, P., Garcia‐Ptacek, S., Johnell, K., Religa, D., Jelic, V., Winblad, B., Ballard, C., et al. (2016) · Acta Psychiatrica Scandinavica

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 42

Psychiatric Disorders Before and After Dementia Diagnosis

Mo, M., Zacarias-Pons, L., Hoang, M. T., Mostafaei, S., Jurado, P. G., Stark, I., Johnell, K., Eriksdotter, M., Xu, H., & Garcia-Ptacek, S. (2023) · JAMA Network Open

Dementia and Cognitive Impairment ResearchMental Health Treatment and Access

Cited by 36

Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data

Bjerkeli, P. J., Perez Vicente, R., Mulinari, S., Johnell, K., & Merlo, J. (2018) · Clinical Epidemiology

Attention Deficit Hyperactivity DisorderPharmaceutical Practices and Patient Outcomes

Cited by 18